StockData

HealthEquity vs Priority Technology

HQY and PRTH side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HQY and PRTH compare

HealthEquity is the larger company, worth 13 times as much as Priority Technology ($8.4B against $652M).

On earnings, Priority Technology is cheaper: it trades at 11.5× trailing earnings, against 36.8× for HealthEquity.

Priority Technology grew revenue faster over the last twelve months (8.9% versus 7.3% for HealthEquity).

HealthEquity scores higher on the StockData Score (15 against 8 for Priority Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHQYPRTH
Size and price
Market cap$8.4B$652M
Share price$101.84$7.91
Change, 1 year0.07%51.0%
Change, 5 years77.5%32.7%
Beta (5Y)0.391.13
Employees2,8141,200
StockData Score
Total score15 (better)8
Valuation score34 (better)
Growth score3 (better)2
Performance score4 (better)1
Health score5 (better)1
Dividend score00
Valuation
P/E36.8×11.5× (better)
P/S6.2×0.7× (better)
P/B4.2×–
EV/EBITDA17.9×7.5× (better)
P/FCF17.3×6.3× (better)
FCF yield5.8%15.9% (better)
Fair value$110.02$15.85
Margin of safety7.4%50.1% (better)
Growth
Revenue growth (TTM)7.3%8.9% (better)
Revenue growth, 5Y average12.4%18.7% (better)
Net income growth (TTM)62.2%–
EPS growth (TTM)67.9%165% (better)
EPS growth, 5Y average83.0% (better)12.3%
Profitability
Gross margin71.2% (better)39.4%
Operating margin25.8% (better)13.8%
Net margin17.4%–
FCF margin35.8% (better)10.4%
Return on equity11.4%–
Return on invested capital9.8%13.8% (better)
Financial health
Debt / equity0.47–
Net debt / EBITDA1.33 (better)4.38
Interest coverage6.7× (better)1.6×
Current ratio2.99 (better)1.10
Altman Z-score4.90 (better)0.77
Piotroski F-score9–
Dividends and buybacks
Buyback yield4.8%–
Shareholder yield4.8% (better)0.00%
Ownership
Held by institutions109%23.6%
Held by insiders1.4%59.7%
Insider net buying, 12 months−$4.1M−$23.8K (better)
Short interest, % of float6.7%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.